𝔖 Bobbio Scriptorium

✦ LIBER ✦

Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension?

✍ Scribed by Beevers, D G; Lip, G Y H

Book ID: 110047623
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 25 KB
Volume: 11
Category: Article
ISSN: 0950-9240
DOI: 10.1038/sj.jhh.1000461

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potential of the angiotensin II receptor

Potential of the angiotensin II receptor 1 blocker eprosartan in the management of patients with hypertension or heart failure

✍ Norman K. Hollenberg 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 151 KB

A Single-Center, Open-Label, Randomized,

A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study

✍ Nobuo Totsuka; Nobuhisa Awata; Katsuhito Takahashi; Hisako Yamamura; Junko Nakam 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Meta-Analysis of effectiveness or lack t

Meta-Analysis of effectiveness or lack thereof of Angiotensin-Converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension

✍ Fabio Angeli; Paolo Verdecchia; Gian Paolo Reboldi; Roberto Gattobigio; Maurizio 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 89 KB

D29 The efficacy of candesartan; an angi

D29 The efficacy of candesartan; an angiotensin II type I receptor antagonist alone or in combination with amlodipine or in combination with amlodipine and hydrochlorothiazide in patients with moderate-to-severe essential hypertension

✍ G.A. MacGregor; T.F. Antonios; F.J. He 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

OCTOGENARIAN PATIENTS WITH HEART FAILURE

OCTOGENARIAN PATIENTS WITH HEART FAILURE AND EJECTION FRACTION <45%, PRE-DISCHARGE PRESCRIPTIONS FOR ANGIOTENSIN CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKERS AND LOWER 30-DAY ALL-CAUSE HOSPITAL READMISSION

✍ Hashim, Taimoor; Bhatia, Vikas; Sanam, Kumar; Parvataneni, Sridivya; Hage, Fadi; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 851 KB

Does aspirin use adversely influence int

Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

✍ Phillip D. Levy; Deepa Nandyal; Robert D. Welch; Jie Lena Sun; Karen Pieper; Jal 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 540 KB